Skip to search formSkip to main contentSkip to account menu

lomeguatrib

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Background/Aim:Multiple Myeloma (MM), characterized by aberrant accumulation of terminally differentiated plasma cells in the… 
2014
2014
Lomeguatrib or Patrin-2 has been formulated to work in combination with Temozolomide. It does so by blocking the action of ATase… 
2013
2013
The treatment of anaplastic astrocytoma (AA) is controversial. New chemotherapeutic approaches are needed for AA treatment… 
2009
2009
To evaluate the tumour response to lomeguatrib and temozolomide (TMZ) administered for 5 consecutive days every 4 weeks in… 
2008
2008
3597 Background: MGMT is implicated in tumor resistance to O6-alkylating agents, since the protein repairs DNA damage before… 
Review
2008
Review
2008
Retroviral-mediated delivery of the P140K mutant O-methylguanine-DNA methyltransferase (MGMT) into hematopoietic stem cells (HSC… 
2008
2008
Chemotherapy, alongside radiotherapy and surgery remains the mainstay of treatment for many cancers. However as our understanding… 
Review
2007
Review
2007
Resistance to O6-alkylating agents can be overcome by depletion of the DNA repair protein, O6-alkylguanine DNA alkyltransferase… 
2006
2006
8016 Background: TheDNA repair enzyme O6-Alkylguanine Alkyltransferase (AGT) directly reverses the O6-methylguanine (O6-MeG) base…